Quick Answer
Bioventus Inc. reported Diluted EPS of $0.33 per share for fiscal year 2025.
Bioventus Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.33 | +158.9% |
| 2024 | -$0.56 | +77.5% |
| 2023 | -$2.49 | +3.9% |
| 2022 | -$2.59 | -1626.7% |
| 2021 | -$0.15 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.05 | +162.5% | -54.5% |
| June 30, 2025 | $0.11 | +127.5% | +375.0% |
| March 31, 2025 | -$0.04 | +50.0% | +50.0% |
| September 30, 2024 | -$0.08 | +33.3% | +80.0% |
| June 30, 2024 | -$0.40 | -566.7% | -400.0% |
| March 31, 2024 | -$0.08 | +96.4% | +33.3% |
| September 30, 2023 | -$0.12 | +93.2% | -100.0% |
| June 30, 2023 | -$0.06 | +45.5% | +97.3% |
- Bioventus Inc. showed an increase of +158.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Bioventus Inc.’s diluted eps has grown by 320.0% (from $0.15 per share (loss) to $0.33 per share).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: